This site is intended for healthcare professionals
News

FDA grants rolling submission to Luveniq for lupus nephritis.- Aurinia Pharmaceuticals

Read time: 1 mins
Published:17th Mar 2020
Condition: Lupus Nephritis
Type: drug
Register for free access to this exclusive healthcare learning resource


Why sign up with Medthority?

Develop your knowledge with our disease and condition focused Learning Zones

Access content from credible sources, including expert-led commentary, videos, podcasts, and webinars as well as clinical trials, treatment information and guidelines 

Personalised dashboard providing updates and recommendations for content within your areas of interest